open access

Vol 92, No 10 (2021)
Clinical vignette
Published online: 2021-09-27
Get Citation

Hyperthyroidism secondary to a hydatidiform mole

Barbara Grzechocinska1, Malgorzata Gajewska1, Maciej Kedzierski1, Sylwia Gajda2, Piotr Jedrzejak1, Miroslaw Wielgos1
·
Pubmed: 34747003
·
Ginekol Pol 2021;92(10):741-742.
Affiliations
  1. 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland
  2. Endocrine Oncology and Nuclear Medicine Clinic, M. Skłodowska-Curie Memorial Institute — Cancer Centre, Warsaw, Poland, Warsaw, Poland

open access

Vol 92, No 10 (2021)
CLINICAL VIGNETTES
Published online: 2021-09-27

Abstract

The case presented in the article is that of a 47-year-old female patient with hyperthyroidism induced by a hydatidiform mole. Attention was drawn to the necessity of preparing the patient for a procedure with drugs that stabilize the hormonal activity of the thyroid. The removal of the hydatidiform mole resulted in gradual normalization of thyroid hormone levels.
The trophoblast has a hormonal activity, secrete hCG (human chorionic gonadotropin).The hCG partial structural homology causes affinity to the TSH (thyroid stimulating hormone) receptor. The higher the weight of the trophoblast, the higher the production and concentration of hCG in the blood.
Therefore, gestational trophoblastic disease may be accompanied by hyperthyroidism. The problem is frequently described, however, due to the risk of developing thyroid storm, it cannot be overlooked [1].

Abstract

The case presented in the article is that of a 47-year-old female patient with hyperthyroidism induced by a hydatidiform mole. Attention was drawn to the necessity of preparing the patient for a procedure with drugs that stabilize the hormonal activity of the thyroid. The removal of the hydatidiform mole resulted in gradual normalization of thyroid hormone levels.
The trophoblast has a hormonal activity, secrete hCG (human chorionic gonadotropin).The hCG partial structural homology causes affinity to the TSH (thyroid stimulating hormone) receptor. The higher the weight of the trophoblast, the higher the production and concentration of hCG in the blood.
Therefore, gestational trophoblastic disease may be accompanied by hyperthyroidism. The problem is frequently described, however, due to the risk of developing thyroid storm, it cannot be overlooked [1].

Get Citation

Keywords

gestational trophoblastic disease; hydatidiform mole; hCG; hyperthyroidism

About this article
Title

Hyperthyroidism secondary to a hydatidiform mole

Journal

Ginekologia Polska

Issue

Vol 92, No 10 (2021)

Article type

Clinical vignette

Pages

741-742

Published online

2021-09-27

Page views

6662

Article views/downloads

684

DOI

10.5603/GP.a2021.0185

Pubmed

34747003

Bibliographic record

Ginekol Pol 2021;92(10):741-742.

Keywords

gestational trophoblastic disease
hydatidiform mole
hCG
hyperthyroidism

Authors

Barbara Grzechocinska
Malgorzata Gajewska
Maciej Kedzierski
Sylwia Gajda
Piotr Jedrzejak
Miroslaw Wielgos

References (4)
  1. Moskovitz, J.B. and M.C. Bond, Molar pregnancy-induced thyroid storm. J Emerg Med, 2010. 38(5): p. : e71–6.
  2. Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid. 1995; 5(5): 425–434.
  3. Kofinas JD, Kruczek A, Sample J, et al. Thyroid storm-induced multi-organ failure in the setting of gestational trophoblastic disease. J Emerg Med. 2015; 48(1): 35–38.
  4. Samra T, Kaur R, Sharma N, et al. Peri-operative concerns in a patient with thyroid storm secondary to molar pregnancy. Indian J Anaesth. 2015; 59(11): 739–742.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl